This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
SAN ANTONIO – July 25, 2023 – Frost & Sullivan recently researched the Malaysian halal pharmaceutical industry and, based on its findings, recognizes Duopharma Biotech Berhad (Duopharma Biotech) with the 2022 Malaysian Company of the Year Award.
SAN ANTONIO – July 27, 2023 – Frost & Sullivan recently researched the Malaysian biosimilars industry and, based on its findings, recognizes Duopharma Biotech Berhad (Duopharma Biotech) with the 2022 Malaysian Company of the Year Award.
His career highlights include igniting US reimbursement pathways for Prescription Digital Therapeutics (PDT), pioneering value-based collaboration between payers and manufacturers, and introducing groundbreaking biotech and healthtech solutions. His role involves fostering alliances within the pharmaceutical and biotech industries.
In 2023, Planview was pleased to sponsor several WHY Summit Events: Basil, Switzerland, and Philadelphia. A year later, we returned to Philadelphia and then headed cross-country to San Francisco for the WHY Summit’s 21st and 22nd American Pharma and Biotech Project, Program, and Portfolio Management Conference.
As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8% growth from 2023 to 2024. What is driving transformation in the pharma industry? increase from 2022. However, the pharma/biopharma industry shows overall stagnant R&D activity.
Small- to mid-sized pharma/biotech players in APAC are rivaling Europe in clinical trials through multiple CRO partnerships in the region, tapping into a population-rich landscape. Let us coach you on your transformational journey, while we actively support you in fostering collaborative initiatives within your industry’s ecosystem.
Global health trends International health trends and collaborations, including disease outbreaks and global health initiatives, can influence domestic healthcare regulations. This is evident in adopting international health standards and collaborative disease control and prevention efforts. billion in 2023 , is projected to reach $43.4
Key Announcements: Announcement 1: R&D Centers of Excellence “Facilities in select ICMR labs will be made available for research by public and private medical college faculty and private sector R&D teams for encouraging collaborative research and innovation.” “A establishing themselves as potential partners for sub-contracting.
Download our full analysis on the top 6 growth opportunities in pharma and biotech. Between 2017 and 2023, the US RLT market saw over 550% growth in total venture capital deals. The post Pharma & Biotech in 2025: The Top 6 Growth Opportunities Shaping the Future appeared first on Frost & Sullivan. Want deeper insights?
San Antonio, TX — 14 th October 2024 — Frost & Sullivan recently conducted an in-depth analysis of the biotech contract research organization (CRO) industry and based on its findings, has awarded Novotech the 2024 Global Company of the Year Award.
In 2023, recruiters adding AI skills to their profiles increased by 14%, signaling growing adoption. As organizations explore AIs potential, they are updating job descriptions (22%) and collaborating with leaders (24%) to adapt jobs for AI integration. Demandsage also notes that AI is making recruitment faster and more efficient.
The 43rd JP Morgan Healthcare Conference , held from January 1316, 2025, in San Francisco, brought together a vibrant ecosystem of global pharma stakeholders, innovative startups, emerging biotech companies, and investors. Key Examples : Johnson & Johnson announced the acquisition of Intra-Cellular Therapies, Inc.
We organize all of the trending information in your field so you don't have to. Join 61,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content